Meet Terry-Ann Burrell, MBA— Chief Financial Officer of Beam Therapeutics & Recursion Board Member.

In the latest episode of our Recursionauts series, Terry-Ann highlights how our AI-based technology can decrease the failure rate in drug discovery and make healthcare more affordable - helping us radically improve people’s lives.

About Recursion:
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine.

Visit https://www.recursion.com/ to learn more.

#biology #chemistry #data #datascience #techbio #drugdiscovery #biotech #biotechnology #healthcare #health #medicine #innovation #ai #artificialintelligence #machinelearning #ml